Psoriatic arthritis
Brodalumab linked to rapid psoriatic arthritis improvement
A biological drug called brodalumab seems to quickly and significantly improve the signs and symptoms of psoriatic arthritis, says data in the Annals of the Rheumatic Diseases.
Continue readingLow incidence of COVID-19 in people with rheumatic disease on biologic therapy
The incidence of COVID-19 was low in people with rheumatic diseases who were being treated with biologic therapies, experts reported at an international conference.
Continue readingPsoriatic arthritis discovery could lead to targeted treatments
Psoriatic arthritis may be activated by the same trigger in different patients, says new research in Nature Communications.
Continue readingAdults with inflammatory arthritis have similar risk of hospital admission as other COVID-19 patients says new research
It has been a concern that people with arthritis may be at increased risk of COVID-19 complications, but a new pair of reports suggests that the risk is the same for adults with and without arthritis.
Continue readingTiny scorpion-derived proteins deliver arthritis drugs to joints
A minute protein in scorpion venom that rapidly accumulates in joint cartilage has been linked with steroids to reverse arthritis inflammation in arthritis. The drugs concentrated in the joints, potentially avoiding the body-wide toxicities and infection risks caused by non-targeted treatment. Continue reading
